ArticleCureus2025

Semaglutide Versus Empagliflozin in Uncontrolled Type 2 Diabetes: A Cohort Study With 18 Months of Follow-Up (SEMPA18).

David Aristizabal-Colorado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.